Imidazopyridine derivatives as potent and selective Polo-like kinase (PLK) inhibitors
- 25 June 2009
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 19 (16) , 4673-4678
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Design of potent thiophene inhibitors of polo-like kinase 1 with improved solubility and reduced protein bindingBioorganic & Medicinal Chemistry Letters, 2009
- Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Design and synthesis of 2-amino-isoxazolopyridines as Polo-like kinase inhibitorsBioorganic & Medicinal Chemistry Letters, 2008
- Tubulin-associated proteins: Aurora and Polo-like kinases as therapeutic targets in cancerCurrent Oncology Reports, 2008
- Pharmacological and Functional Comparison of the Polo-like Kinase Family: Insight into Inhibitor and Substrate SpecificityBiochemistry, 2007
- Targeting polo-like kinase 1 for cancer therapyNature Reviews Cancer, 2006
- Polo-like kinases and oncogenesisOncogene, 2005
- Polo-like kinases (Plks) and cancerOncogene, 2005
- Regulation of cell cycle checkpoints by polo-like kinasesOncogene, 2005
- Structure and function of Polo-like kinasesOncogene, 2005